The new world: hematopoietic stem cell transplant during a pandemic.
Curr Opin Hematol
; 28(6): 389-393, 2021 11 01.
Article
in English
| MEDLINE | ID: covidwho-1377995
ABSTRACT
PURPOSE OF REVIEW Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted every facet of hematopoietic cell transplantation. This article reviews the adjustments to recipient and donor care that occurred in response to this unprecedented event. RECENT FINDINGS:
Transplant centers modified algorithms, patient flow, education, and how we provided care. Our donor center partners reworked how donors were evaluated and products delivered to the transplant center. Our professional societies provided guidelines for patient and donor care and rapidly modified these based upon the never-ending stream of new data learned about SARS-CoV-2. Our research organizations provided rapid analyses to ensure the care modifications necessitated did not have a profound negative impact on our patients or donors.SUMMARY:
The efforts of transplant providers and donor centers worldwide allowed patients to receive the transplant needed with assurances that they were receiving the best care available despite the worldwide challenge.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Tissue Donors
/
Algorithms
/
Practice Guidelines as Topic
/
Hematopoietic Stem Cell Transplantation
/
Transplant Recipients
/
SARS-CoV-2
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Curr Opin Hematol
Journal subject:
Hematology
Year:
2021
Document Type:
Article
Affiliation country:
MOH.0000000000000680
Similar
MEDLINE
...
LILACS
LIS